川宁生物

- 301301

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018 
川宁生物(301301) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入319,542.67152,321.82482,333.50358,133.34241,719.92
营业收入319,542.67152,321.82482,333.50358,133.34241,719.92
二、营业总成本226,406.29109,863.98364,883.00276,837.23190,301.86
营业成本206,705.3299,893.50330,039.71250,931.85173,083.21
营业税金及附加4,643.351,971.816,664.605,414.423,728.18
销售费用1,159.56384.742,256.651,462.89884.29
管理费用8,249.044,679.0114,313.1510,707.387,343.65
财务费用2,770.981,266.716,083.104,414.972,905.36
研发费用2,878.051,668.225,525.813,905.722,357.17
资产减值损失----------
公允价值变动收益-22.46-51.99-118.40-181.84-539.48
投资收益-631.21-306.55-1,355.07-1,158.12-745.96
其中:对联营企业和合营企业的投资收益-10.56-3.89-14.55-10.58-6.24
汇兑收益----------
三、营业利润91,968.0542,322.75112,139.9777,673.7747,535.71
加:营业外收入6.744.54197.9919.0817.45
减:营业外支出1,059.08135.33566.85833.90577.12
其中:非流动资产处置损失----------
四、利润总额90,915.7142,191.96111,771.1176,858.9546,976.04
减:所得税费用14,282.956,929.3517,714.6112,843.997,889.18
五、净利润76,632.7635,262.6194,056.5064,014.9639,086.87
归属于母公司所有者的净利润76,630.4135,261.4994,056.4064,014.9839,086.87
少数股东损益2.351.120.10-0.02-0.00
六、每股收益
基本每股收益(元/股)0.34000.16000.42000.29000.1800
稀释每股收益(元/股)0.34000.16000.42000.29000.1800
七、其他综合收益----------
八、综合收益总额76,632.7635,262.6194,056.5064,014.9639,086.87
归属于母公司所有者的综合收益总额76,630.4135,261.4994,056.4064,014.9839,086.87
归属于少数股东的综合收益总额2.351.120.10-0.02-0.00
下载全部历史数据到excel中 返回页顶